Melanoma-derived EVs, by incorporating inducible heat shock protein 86 (HSP86), activate TLR4 on myeloid cells, which in turn activates NF-κB to upregulate the expression of PD-L1. This evidence concerns the gene HSP90AA1 and melanoma.